Friday , 30 October 2026
Home Health & Fitness Nigeria Ebola Case Triggers WHO Alert For Regional Vigilance
Health & FitnessNews

Nigeria Ebola Case Triggers WHO Alert For Regional Vigilance

‏

The World Health Organisation has called for heightened vigilance across Africa after Nigeria confirmed its first imported Ebola case.

WHO Director-General Dr Tedros Ghebreyesus made the call on Wednesday on X, after the Federal Ministry of Health confirmed the case.

Nigeria’s case is a woman who recently travelled from Uganda. She arrived in Nigeria, started showing symptoms on October 7, and tested positive for the Bundibugyo strain of Ebola on October 20 in Abuja. She is now in isolation in a private hospital in the FCT.

The Federal Government says 44 contacts have been identified so far — including health workers, patients, caregivers and travel contacts — and contact tracing is ongoing.

Tedros said WHO and partners are working with Nigeria, Kenya and DR Congo to strengthen the response.

“Contact tracing is ongoing. WHO and partners are working with the governments of Nigeria, Kenya and the DRC to strengthen the overall outbreak response,” he said.

He urged countries in the region to sustain high readiness to detect cases early, prevent further spread and protect health workers and communities.

WHO also advised countries not to impose travel or trade restrictions on affected countries.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

China Says It Takes Mbappé’s Apology Seriously After Mao Comment

  China has reacted to Kylian Mbappé’s apology over his comments about...

FG: Workers To Get N70,000 Monthly Transport Support From November

Federal workers will begin to receive a N70,000 monthly transport support from...

Tinubu seeks fresh $20.5bn, €1.04bn foreign loans to fund infrastructure

  In a bid to close Nigeria’s infrastructure financing gap, President Bola...

DR Congo Launches Ebola Vaccine Trial Amid Rising Outbreak

  The Democratic Republic of Congo has launched the first clinical trial...